FDA Inspection
CA-BOTANA INTERNATIONALCA-BOTANA INTERNATIONAL – FDA Inspection, Nov 12, 2019
Record Details
This FDA Inspection record concerns CA-BOTANA INTERNATIONAL, with an inspection on November 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- CA-BOTANA INTERNATIONAL
- Inspection Date
- November 12, 2019
- Product Type
- Drugs
View Company Profile
ID · e6ea264f-ca6d-4be2-9592-e9fca6276737
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1109655
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.150(b)Recall facilitation
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.89Quarantine of Rejected Components et. al.
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CA-BOTANA INTERNATIONAL
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| January 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CA-BOTANA INTERNATIONAL
- FDA Inspection 1265869 - 2025-04-04
- FDA Inspection 963353 - 2016-01-12
- FDA Inspection 819672 - 2013-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.